254 related articles for article (PubMed ID: 29450)
1. Dopamine and schizophrenia.
Crow TJ; Johnstone EC; Longden A; Owen F
Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
[No Abstract] [Full Text] [Related]
2. [Schizophrenia and dopamine (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
[No Abstract] [Full Text] [Related]
3. The relationship between epilepsy and schizophrenia: a biochemical hypothesis.
Trimble M
Biol Psychiatry; 1977 Apr; 12(2):299-304. PubMed ID: 15665
[TBL] [Abstract][Full Text] [Related]
4. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
5. [Etiology of schizophrenia: neurochemical aspects].
de las Cuevas Castresana C; González de Rivera JL
Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
[No Abstract] [Full Text] [Related]
6. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality].
Toru M; Watanabe S; Kaneno S
Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768
[No Abstract] [Full Text] [Related]
7. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
Kety SS
Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
[No Abstract] [Full Text] [Related]
8. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
9. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
Chouinard G; Annable L; Ross-Chouinard A
Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
[No Abstract] [Full Text] [Related]
10. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
[No Abstract] [Full Text] [Related]
11. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
Fredrickson P; Richelson E
J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
[TBL] [Abstract][Full Text] [Related]
12. [Current concepts of the effects of neuroleptics].
Kostowski W; Płaźnik A
Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
[No Abstract] [Full Text] [Related]
13. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
[No Abstract] [Full Text] [Related]
14. [Findings of biochemical research on schizophrenia (author's transl)].
Ackenheil M; Hippius H; Matussek N
Nervenarzt; 1978 Nov; 49(11):634-49. PubMed ID: 31575
[No Abstract] [Full Text] [Related]
15. [Schizophrenia as a dopamine excess syndrome].
Toru M
Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
[No Abstract] [Full Text] [Related]
16. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
Diamond BI; Borison RL
Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
[No Abstract] [Full Text] [Related]
17. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
18. [Dopaminergic receptor activity and the evolution of schizophrenia].
Fodoreanu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
[No Abstract] [Full Text] [Related]
19. [Antipsychotic drugs and drugs inducing psychoses].
Deniker P
Acta Psychiatr Belg; 1983; 83(3):239-54. PubMed ID: 6138922
[TBL] [Abstract][Full Text] [Related]
20. [A biochemical theory of schizophrenia].
Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
